HydroGraph Clean Power Inc. develops and commercializes graphene materials, including Fractal Graphene™, produced through its proprietary explosion-synthesis process. Company news commonly covers production scale-up through Hyperion reactors, research and production capabilities tied to its Austin operations, and regulatory clearances for commercial graphene sales under U.S. EPA TSCA, UK REACH, and EU REACH frameworks.
Updates also include qualified compounding partners for graphene-enhanced polymer materials, application work in areas such as masterbatches and protective coatings, and management or governance changes. These developments reflect HydroGraph’s focus on commercial adoption of high-purity graphene across industrial materials markets.
HydroGraph (OTCQB: HGRAF) signed a non-binding LOI with Sparc Technologies on March 23, 2026 to test and potentially supply HydroGraph’s Fractal Graphene™ for Sparc’s ecosparc® additives in protective coatings.
Initial water-based tests showed 39%–60% reduction in scribe corrosion creep (ASTM D1654-08); ISO 12944 solvent-based testing (4,200 hours) is planned, and a definitive commercial agreement is targeted within ~12 months if testing succeeds.
HydroGraph (OTCQB: HGRAF) certified Broadway Colours as a qualified Compounding Partner on March 17, 2026, expanding HydroGraph's commercial graphene masterbatch capabilities across the UK and Europe. Broadway completed HydroGraph’s technical and commercial qualification and will integrate Fractal Graphene™ into scalable thermoplastic formulations.
Broadway operates a 90,000-square-foot facility, expanded compounding capacity by >60%, and already markets GrapheneXcelTM masterbatches for improved mechanical, conductive, and barrier properties.
HydroGraph (CSE: HG, OTCQB: HGRAF) received key regulatory clearances on Feb 24, 2026: a US EPA TSCA Section 5(e) Order (PMN P-24-0086/P-24-0087) plus confirmed UK REACH and EU REACH registrations (UK-01-8788107436-0-0006; 01-2120768618-38-0012). These approvals authorize commercial manufacture, supply, and defined uses of HydroGraph's graphene materials across the US, UK, and EU, enabling customer scale-up under specified compliance conditions.
The EPA order includes operational controls, workplace protections, and recordkeeping requirements; the REACH registrations provide regulatory clarity for UK and EU commercial activity and market expansion.
HydroGraph (OTCQB: HGRAF) appointed John Neale as Chief Financial Officer, effective February 20, 2026. Mr. Neale will oversee finance, legal, HR and technology and brings more than 20 years of finance leadership in technology, B2B and manufacturing.
The company granted Mr. Neale 938,538 stock options exercisable at $4.47 per share for five years, vesting 25% annually beginning February 20, 2027.
HydroGraph (OTCQB: HGRAF) qualified Hubron International for its Fractal Graphene™ Compounding Partner Program, adding a Manchester-based compounding and masterbatch specialist to expand commercial adoption in thermoplastics. Hubron supplies 85%+ export volumes, runs 24/7 manufacturing with multiple compounding technologies, and brings carbon nanomaterial experience.
This partnership aims to broaden market access across automotive, construction, electronics, film, pipe, wire and cable, and technical compounding channels, and supports toll compounding and branded supply models.
HydroGraph (OTCQB: HGRAF) has commenced construction of two additional Hyperion graphene reactors to scale production of its FGA-1 ultra-pure fractal graphene. Each reactor is expected to produce approximately 10 tons per year, adding roughly 20 tons/year of capacity overall. The units match the existing commercial unit footprint (about 6 ft × 6 ft × 18 ft) and are scheduled for commissioning in January and February 2026 in Manhattan, Kansas, before planned relocation to the company’s Austin, Texas facilities under construction. Longer-term plans call for a broader manufacturing expansion in south Texas with dedicated acetylene supply via pipeline. Initial commissioning will support validation, performance testing, and process optimization prior to permanent installation.
HydroGraph (OTCQB: HGRAF) has upgraded its collaboration with the Graphene Engineering Innovation Centre (GEIC) at the University of Manchester from Tier 2 to Tier 1 on Jan 6, 2026.
The move secures a dedicated HydroGraph laboratory inside the GEIC, broader access to facilities and expertise, and aims to accelerate laboratory validation into industrial trials.
HydroGraph and GEIC report a commercial pipeline of more than 75 projects across medical devices, composites and coatings. HydroGraph has scaled production from pilot volumes to about 1 ton per month and expects to reach full commercial scale as additional reactors and a new Texas facility progress throughout 2026. The expanded relationship also supports deeper collaboration with strategic partners including the U.S. Army Research Laboratory (ARL).
HydroGraph (OTCQB: HGRAF) appointed James Baker to its Technical Advisory Board effective December 9, 2025. Mr. Baker brings 30+ years in advanced materials, aerospace, defence, and graphene commercialisation, including 12 years leading graphene and 2D materials activities at University of Manchester and serving as CEO of the Graphene Engineering Innovation Centre.
Mr. Baker will step down from his university role end of January 2026, support Graphene@Manchester's transition, and advise HydroGraph on scale-up, application development, supply-chain readiness, and commercialisation.
HydroGraph (OTCQB:HGRAF) provided a shareholder letter dated October 22, 2025 summarizing progress toward commercializing 99.8% pure fractal graphene.
Key facts: the company has produced ~1 ton to date, maintains >500 kg inventory, serves 60+ customers and a pipeline of 65+ projects, and currently runs one Hyperion reactor at ~1 ton/month with plans to scale to ~30 tons/year from additional reactors. HydroGraph leased an Austin, TX site (opening Spring 2026) and aims to build a 70,000 sq ft Texas facility (groundbreaking targeted Q1 2026) to host 5 reactors and ultimately >350 tons/year. The company cites acetylene access as the primary input constraint and is securing pipeline-adjacent supply. A settlement requires issuance of 750,000 common shares expected October 28, 2025.
HydroGraph (OTCQB: HGRAF) announced that President & CEO Kjirstin Breure will present at the Emerging Growth Conference on Thursday, October 23, 2025 at 11:25 AM ET. The presentation will include an overview and may open for questions; advance questions can be sent to Questions@EmergingGrowth.com.
Investors can register for the live webcast and updates at the conference registration link, and an archived webcast will be posted on EmergingGrowth.com and HydroGraph's Investor section at hydrograph.com. For investor meetings, contact Emerging Growth conference representatives or Matt Kreps, Vice President Investor Relations, at matt.kreps@hydrograph.com.